Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8227436 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 7 Pages |
Abstract
The combination of salvage radiosurgery and bevacizumab to treat recurrent malignant gliomas is well tolerated and seems to be associated with improved outcomes. Prospective multiinstitutional studies are required to determine efficacy and long-term toxicity with this approach.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kyle C. M.D., James J. M.D., John H. M.D., Ph.D., David A. M.D., Annick M.D., Katherine B. M.D., Ph.D., Henry S. M.D., Christopher G. M.D., John P. M.D., Ph.D.,